AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Relay Therapeutics (RLAY) Receives Buy Rating from Leerink Partners with $12.00 Price Target
ByAinvest
Tuesday, Aug 12, 2025 5:37 am ET1min read
Relay Therapeutics (RLAY) has received a Buy rating and $12.00 price target from Leerink Partners analyst Andrew Berens. This follows a Buy rating from Barclays's Peter Lawson. However, TR | OpenAI reiterated a Hold rating on RLAY. Corporate insider sentiment is negative with an increase in insiders selling their shares. RLAY's market cap is $560.3M and P/E ratio is -1.67.
Relay Therapeutics (RLAY) has seen mixed analyst ratings and a shift in insider sentiment, which may influence its stock price. The company has received a Buy rating and a $12.00 price target from Leerink Partners analyst Andrew Berens, following a similar Buy rating from Barclays' Peter Lawson [1]. However, TR | OpenAI reiterated a Hold rating on RLAY [2]. Additionally, corporate insider sentiment has turned negative, with an increase in insiders selling their shares.The company's market capitalization stands at $560.3M, with a P/E ratio of -1.67, indicating a challenging valuation. The mixed analyst ratings suggest a cautious approach from some investors, while the negative insider sentiment may also be a red flag. Despite these factors, the company's strong performance in the past year, as it has outperformed its overall industry, may attract long-term investors.
In the current month, RLAY has received 9 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings, with an average analyst price target of $11.38 [3]. The company's next quarterly earnings estimate is -$0.43, with a range of -$0.51 to -$0.32 [4]. The previous quarter's EPS was -$0.41, and RLAY beat its EPS estimate 100.00% of the time in the past 12 months [4]. The sales forecast for the next quarter is $160.00K, with a range of $0.00 to $680.00K [4].
Given these factors, investors should closely monitor RLAY's financial performance and analyst ratings to make informed decisions.
References:
[1] https://www.tipranks.com/stocks/rlay/forecast
[2] https://www.tipranks.com/stocks/rlay/forecast
[3] https://www.tipranks.com/stocks/rlay/forecast
[4] https://www.tipranks.com/stocks/rlay/forecast
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet